Villaroya, Jeane C.
HRN: 22-12-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/25/2024
07/02/2024
IV
500 Mg
Q8
SP NSVD; IUFD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes